Early tumor dissemination, but late metastasis: insights into tumor dormancy
- PMID: 20501952
- PMCID: PMC2877965
- DOI: 10.1172/JCI43424
Early tumor dissemination, but late metastasis: insights into tumor dormancy
Abstract
The classical model of metastasis is that tumor cell dissemination occurs late in tumor development, after the primary tumor has grown, and that only then will tumor cells invade the local tissue, enter the blood or lymphatic vessels, and colonize new sites to cause metastases. However, evidence increasingly indicates that single tumor cells spread to distant sites much earlier than previously believed. In this issue of the JCI, Eyles and colleagues provide new insight into the mechanisms underlying early tumor cell dissemination, formation of metastases, and tumor immunosurveillance using transgenic mice that spontaneously develop melanomas of the uvea. The authors provide striking evidence that tumor cells start to disseminate during the initial steps of tumor development, that late appearing metastases arise from these early disseminated tumor cells, and that CD8+ T cells inhibit the growth of disseminated tumor cells, surprisingly, not by cytotoxic effects, but through cytostatic effects.
Figures

Comment on
-
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.J Clin Invest. 2010 Jun;120(6):2030-9. doi: 10.1172/JCI42002. Epub 2010 May 24. J Clin Invest. 2010. PMID: 20501944 Free PMC article.
Similar articles
-
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.J Clin Invest. 2010 Jun;120(6):2030-9. doi: 10.1172/JCI42002. Epub 2010 May 24. J Clin Invest. 2010. PMID: 20501944 Free PMC article.
-
Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.Breast Cancer Res. 2020 Oct 28;22(1):116. doi: 10.1186/s13058-020-01357-9. Breast Cancer Res. 2020. PMID: 33115528 Free PMC article.
-
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.Front Immunol. 2024 Feb 14;15:1336023. doi: 10.3389/fimmu.2024.1336023. eCollection 2024. Front Immunol. 2024. PMID: 38426087 Free PMC article. Review.
-
Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.Ophthalmology. 2011 Dec;118(12):2351-60. doi: 10.1016/j.ophtha.2011.05.025. Epub 2011 Aug 11. Ophthalmology. 2011. PMID: 21835473
-
Cancer Metastases: Early Dissemination and Late Recurrences.Cancer Growth Metastasis. 2015 Nov 29;8:43-9. doi: 10.4137/CGM.S31244. eCollection 2015. Cancer Growth Metastasis. 2015. PMID: 26640389 Free PMC article. Review.
Cited by
-
Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells.Sci Rep. 2019 Apr 11;9(1):5926. doi: 10.1038/s41598-019-42251-5. Sci Rep. 2019. PMID: 30976078 Free PMC article.
-
Clinical protein science in translational medicine targeting malignant melanoma.Cell Biol Toxicol. 2019 Aug;35(4):293-332. doi: 10.1007/s10565-019-09468-6. Epub 2019 Mar 21. Cell Biol Toxicol. 2019. PMID: 30900145 Free PMC article.
-
Cell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model.Biol Direct. 2017 Aug 11;12(1):18. doi: 10.1186/s13062-017-0188-z. Biol Direct. 2017. PMID: 28800767 Free PMC article.
-
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.Cancers (Basel). 2025 Feb 27;17(5):832. doi: 10.3390/cancers17050832. Cancers (Basel). 2025. PMID: 40075679 Free PMC article.
-
Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.ISRN Dermatol. 2012;2012:828146. doi: 10.5402/2012/828146. Epub 2012 Jan 11. ISRN Dermatol. 2012. PMID: 22363864 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials